1. Home
  2. BZUN vs GBIO Comparison

BZUN vs GBIO Comparison

Compare BZUN & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BZUN
  • GBIO
  • Stock Information
  • Founded
  • BZUN 2007
  • GBIO 2016
  • Country
  • BZUN China
  • GBIO United States
  • Employees
  • BZUN N/A
  • GBIO N/A
  • Industry
  • BZUN Catalog/Specialty Distribution
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • BZUN Consumer Discretionary
  • GBIO Health Care
  • Exchange
  • BZUN Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • BZUN 131.7M
  • GBIO 29.2M
  • IPO Year
  • BZUN N/A
  • GBIO 2020
  • Fundamental
  • Price
  • BZUN $2.61
  • GBIO $0.35
  • Analyst Decision
  • BZUN Buy
  • GBIO Strong Buy
  • Analyst Count
  • BZUN 2
  • GBIO 4
  • Target Price
  • BZUN $3.20
  • GBIO $7.33
  • AVG Volume (30 Days)
  • BZUN 262.6K
  • GBIO 1.1M
  • Earning Date
  • BZUN 08-27-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • BZUN N/A
  • GBIO N/A
  • EPS Growth
  • BZUN N/A
  • GBIO N/A
  • EPS
  • BZUN N/A
  • GBIO N/A
  • Revenue
  • BZUN $1,310,110,798.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • BZUN $5.27
  • GBIO N/A
  • Revenue Next Year
  • BZUN $3.46
  • GBIO N/A
  • P/E Ratio
  • BZUN N/A
  • GBIO N/A
  • Revenue Growth
  • BZUN 6.77
  • GBIO 146.47
  • 52 Week Low
  • BZUN $2.11
  • GBIO $0.30
  • 52 Week High
  • BZUN $4.38
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • BZUN 46.57
  • GBIO 45.19
  • Support Level
  • BZUN $2.48
  • GBIO $0.31
  • Resistance Level
  • BZUN $2.70
  • GBIO $0.37
  • Average True Range (ATR)
  • BZUN 0.15
  • GBIO 0.03
  • MACD
  • BZUN 0.00
  • GBIO -0.00
  • Stochastic Oscillator
  • BZUN 29.18
  • GBIO 39.09

About BZUN Baozun Inc.

Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: